$1.54 Billion is the total value of Cormorant Asset Management, LP's 65 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 29.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | Sell | ANAPTYSBIO INC | $113,239,000 | +29.2% | 1,135,000 | -8.0% | 7.36% | +13.5% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $85,251,000 | -9.9% | 1,810,000 | -5.6% | 5.54% | -20.8% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $83,515,000 | +14.0% | 1,370,000 | -8.7% | 5.43% | +0.1% |
| NKTR | Sell | NEKTAR THERAPEUTICScall | $80,979,000 | -9.3% | 1,328,400 | -27.3% | 5.26% | -20.3% |
| AVRO | Sell | AVROBIO INC | $77,431,000 | +79.8% | 1,492,784 | -1.0% | 5.03% | +57.9% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $74,187,000 | -21.8% | 4,172,498 | -3.2% | 4.82% | -31.3% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $54,275,000 | +23.0% | 3,556,669 | -1.2% | 3.53% | +8.1% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $53,962,000 | +242.9% | 660,000 | +46.7% | 3.51% | +201.0% |
| TSRO | Buy | TESARO INC | $48,763,000 | +99.4% | 1,250,000 | +127.3% | 3.17% | +75.1% |
| IFRX | Sell | INFLARX NV | $46,042,000 | -4.0% | 1,341,540 | -9.8% | 2.99% | -15.7% |
| MYOK | Sell | MYOKARDIA INC | $45,640,000 | +20.1% | 700,000 | -8.8% | 2.97% | +5.4% |
| PRNB | New | PRINCIPIA BIOPHARMA INC | $43,447,000 | – | 1,486,898 | +100.0% | 2.82% | – |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $40,673,000 | -0.5% | 1,326,136 | -13.1% | 2.64% | -12.6% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $36,946,000 | +23.8% | 1,500,659 | -1.3% | 2.40% | +8.7% |
| QTNT | Buy | QUOTIENT LTD | $36,618,000 | +6.3% | 4,850,000 | +13.0% | 2.38% | -6.7% |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $35,937,000 | +21.9% | 1,100,000 | -15.4% | 2.34% | +7.1% |
| GTHX | Sell | G1 THERAPEUTICS INC | $33,491,000 | +7.0% | 640,481 | -11.0% | 2.18% | -6.0% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $33,248,000 | +22.2% | 1,552,911 | -1.3% | 2.16% | +7.3% |
| SLDB | Sell | SOLID BIOSCIENCES INC | $31,635,000 | +29.4% | 670,513 | -2.3% | 2.06% | +13.7% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $29,663,000 | -15.0% | 380,000 | -30.9% | 1.93% | -25.4% |
| OMER | New | OMEROS CORPcall | $27,752,000 | – | 1,136,900 | +100.0% | 1.80% | – |
| SAGE | Sell | SAGE THERAPEUTICS INC | $26,838,000 | -28.4% | 190,000 | -20.7% | 1.74% | -37.2% |
| ZGNX | New | ZOGENIX INC | $24,800,000 | – | 500,000 | +100.0% | 1.61% | – |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $24,801,000 | +0.3% | 350,000 | -5.8% | 1.61% | -11.9% |
| OMER | Sell | OMEROS CORP | $24,410,000 | +2.4% | 1,000,000 | -23.9% | 1.59% | -10.0% |
| TCDA | Sell | TRICIDA INC | $22,442,000 | -19.7% | 734,588 | -21.4% | 1.46% | -29.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $21,516,000 | +14.6% | 175,000 | -8.4% | 1.40% | +0.6% |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $21,191,000 | +53.1% | 831,000 | 0.0% | 1.38% | +34.5% | |
| TSRO | New | TESARO INCcall | $19,505,000 | – | 500,000 | +100.0% | 1.27% | – |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $18,868,000 | -3.8% | 410,000 | -8.9% | 1.23% | -15.6% |
| INCY | Buy | INCYTE CORP | $17,961,000 | +34.0% | 260,000 | +30.0% | 1.17% | +17.6% |
| ZLAB | Buy | ZAI LAB LTDadr | $15,743,000 | +103.2% | 808,166 | +142.6% | 1.02% | +78.5% |
| ARGX | Sell | ARGEN SEsponsored adr | $14,410,000 | -37.6% | 190,000 | -31.8% | 0.94% | -45.1% |
| INSP | Sell | INSPIRE MED SYS INC | $12,624,000 | +8.9% | 300,000 | -7.7% | 0.82% | -4.3% |
| ZGNX | New | ZOGENIX INCcall | $12,400,000 | – | 250,000 | +100.0% | 0.81% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $9,763,000 | -13.2% | 260,000 | -8.7% | 0.64% | -23.8% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $9,120,000 | -18.7% | 600,000 | -10.3% | 0.59% | -28.6% |
| RUBY | New | RUBIUS THERAPEUTICS INC | $8,749,000 | – | 364,559 | +100.0% | 0.57% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $8,558,000 | – | 1,271,687 | +100.0% | 0.56% | – |
| SPPI | Sell | SPECTRUM PHARMACEUTICALS INC | $8,400,000 | -66.6% | 500,000 | -58.3% | 0.55% | -70.7% |
| AMRN | New | AMARIN CORP PLCspons adr new | $8,135,000 | – | 500,000 | +100.0% | 0.53% | – |
| NERV | MINERVA NEUROSCIENCES INC | $7,629,000 | +52.1% | 607,903 | 0.0% | 0.50% | +33.7% | |
| REPL | New | REPLIMUNE GROUP INC | $7,531,000 | – | 467,792 | +100.0% | 0.49% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $7,260,000 | -30.8% | 500,000 | -4.9% | 0.47% | -39.3% |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $6,400,000 | -27.2% | 500,000 | -9.0% | 0.42% | -36.0% |
| CFRX | Sell | CONTRAFECT CORP | $6,210,000 | -17.2% | 3,000,000 | -11.6% | 0.40% | -27.2% |
| SRRK | SCHOLAR ROCK HLDG CORP | $5,410,000 | +65.1% | 210,078 | 0.0% | 0.35% | +45.5% | |
| HRTX | Sell | HERON THERAPEUTICS INC | $5,381,000 | -27.5% | 170,000 | -11.0% | 0.35% | -36.2% |
| YMAB | New | Y MABS THERAPEUTICS INC | $5,312,000 | – | 200,000 | +100.0% | 0.34% | – |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $4,949,000 | -59.9% | 125,000 | -61.3% | 0.32% | -64.7% |
| TBIO | TRANSLATE BIO, INC | $4,546,000 | -20.9% | 454,550 | 0.0% | 0.30% | -30.6% | |
| EIDX | EIDOS THERAPEUTICS INC | $3,851,000 | -48.3% | 385,846 | 0.0% | 0.25% | -54.7% | |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $3,685,000 | -46.1% | 250,000 | -12.8% | 0.24% | -52.6% |
| AKCA | New | AKCEA THERAPEUTICS INCput | $3,502,000 | – | 100,000 | +100.0% | 0.23% | – |
| SGMO | Sell | SANGAMO BIOSCIENCES INC | $3,390,000 | -37.5% | 200,000 | -47.7% | 0.22% | -45.3% |
| MGTX | Sell | MEIRAGTX HOLDINGS PLC | $3,245,000 | +18.7% | 238,579 | -0.0% | 0.21% | +4.5% |
| ITRM | Sell | ITERUM THERAPEUTICS PLC | $3,196,000 | -41.3% | 476,968 | -4.6% | 0.21% | -48.4% |
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $3,000,000 | -11.2% | 300,000 | -37.3% | 0.20% | -22.0% |
| Sell | TRILLIUM THERAPEUTICS INC | $2,900,000 | -15.7% | 500,000 | -12.8% | 0.19% | -26.0% | |
| XLRN | Sell | ACCELERON PHARMA INC | $2,862,000 | -17.7% | 50,000 | -30.2% | 0.19% | -27.6% |
| CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $2,460,000 | -80.8% | 400,000 | -66.7% | 0.16% | -83.1% |
| ARQL | New | ARQULE INC | $1,698,000 | – | 300,000 | +100.0% | 0.11% | – |
| QTRX | Sell | QUANTERIX CORP | $1,177,000 | -90.3% | 54,945 | -93.5% | 0.08% | -91.5% |
| ONSIW | ONCOBIOLOGICS INC - CW17 -A*w exp 02/18/201 | $9,000 | -55.0% | 416,666 | 0.0% | 0.00% | 0.0% | |
| CLRBW | CELLECTAR BIOSCIENCES-CW19*w exp 08/20/201 | $4,000 | -60.0% | 52,999 | 0.0% | 0.00% | -100.0% | |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -382,139 | -100.0% | -0.19% | – |
| Exit | INTEC PHARMA LTD JERUSALEM | $0 | – | -773,816 | -100.0% | -0.25% | – | |
| GEMP | Exit | GEMPHIRE THERAPEUTICS INC | $0 | – | -1,041,635 | -100.0% | -0.78% | – |
| Exit | OMEROS CORPcall | $0 | – | -969,000 | -100.0% | -1.30% | – | |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -957,821 | -100.0% | -1.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-29 |
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.